Advanced Enzyme EXPLODES 9% After Stunning Q2 Results! Profit & Revenue Skyrocket – What Investors NEED to Know NOW!

Advanced Enzyme Technologies Ltd. saw its stock price climb up to 9% on Wednesday, November 12, 2025, driven by its impressive September quarter financial results. The company announced that its net profit grew by 32% compared to the same quarter last year, reaching ₹43.3 crore from ₹33 crore. Revenue also saw a substantial increase of 26.4%, rising to ₹184.5 crore from ₹146 crore year-on-year. The company's operational efficiency was highlighted by a 42% growth in Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) to ₹60 crore. Furthermore, the EBITDA margin expanded by 350 basis points from the previous year to stand at 32.5%. The stock was trading at ₹329.75, with trading volumes significantly higher than average, indicating strong investor interest. Despite a year-to-date decline of 6%, the stock has gained approximately 6% over the last month. The company did not declare any dividend for this quarter.

Impact This news is highly positive for Advanced Enzyme Technologies, as strong financial results and increased trading volumes often lead to enhanced investor confidence and potentially higher stock prices. Investors will be closely watching for sustained growth in future quarters. Rating: 7/10.

Definitions: EBITDA: Earnings Before Interest, Tax, Depreciation and Amortisation. This metric measures a company's operational profitability before accounting for financing, taxes, and non-cash expenses like depreciation and amortization. Basis points: A unit of measure used in finance to denote the percentage change in a financial instrument. One basis point is equal to 0.01% (1/100th of a percent). Therefore, 350 basis points equate to 3.5%.